Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sedana Medical AB ( (SE:SEDANA) ) just unveiled an update.
Sedana Medical AB reported a strong sales growth of 21% in Q2 2025, driven by increased sales and reduced operating costs, despite facing challenges from unrealized currency effects. The company continues its registration preparation work in the USA, impacting cash flow from investments in intangible assets, while maintaining a focus on improving cash flow from operations outside the US.
More about Sedana Medical AB
Sedana Medical AB is a pioneering medtech and pharmaceutical company that specializes in inhaled sedation to enhance patient care during and after sedation. The company offers solutions through its medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane) for mechanically ventilated patients in intensive care. Established in 2005, Sedana Medical is listed on Nasdaq Stockholm and headquartered in Stockholm, Sweden.
Average Trading Volume: 337,226
Current Market Cap: SEK1.14B
Learn more about SEDANA stock on TipRanks’ Stock Analysis page.